Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma
Authors
Keywords
Hepatocellular carcinoma, IRAK1, Proliferation, Cell cycle, Subcutaneous tumor, Apoptosis
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 35, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-13
DOI
10.1186/s13046-016-0413-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
- (2015) Xin Wang et al. DIGESTIVE DISEASES AND SCIENCES
- Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis
- (2015) Bo Su et al. HEPATOLOGY
- Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies
- (2015) Zhaoyang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis
- (2015) Lei Deng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1
- (2015) Binhui Xie et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
- (2015) Li Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice
- (2015) Xinli Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
- (2015) Mark A. Feitelson et al. SEMINARS IN CANCER BIOLOGY
- IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
- (2015) Zhen Ning Wee et al. Nature Communications
- Targeting IRAK1 in T-cell acute lymphoblastic leukemia
- (2015) Charles Dussiau et al. Oncotarget
- IRAK1: oncotarget in MDS and AML
- (2015) Levi J. Beverly et al. Oncotarget
- IRAK signalling in cancer
- (2014) G W Rhyasen et al. BRITISH JOURNAL OF CANCER
- A cell-intrinsic role for TLR2–MYD88 in intestinal and breast epithelia and oncogenesis
- (2014) Ferenc A. Scheeren et al. NATURE CELL BIOLOGY
- Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
- (2013) Garrett W. Rhyasen et al. CANCER CELL
- Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma
- (2012) Keisuke Kohga et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Augmentation of Therapeutic Responses in Melanoma by Inhibition of IRAK-1,-4
- (2012) R. Srivastava et al. CANCER RESEARCH
- Interleukin-1 receptor associated kinases-1/4 inhibition protects against acute hypoxia/ischemia-induced neuronal injury in vivo and in vitro
- (2011) Y.-F. Yang et al. NEUROSCIENCE
- Expression of Interleukin-1 Receptor-Associated Kinase-1 in Non-Small Cell Lung Carcinoma and Preneoplastic Lesions
- (2009) C. Behrens et al. CLINICAL CANCER RESEARCH
- IRAK-4 Inhibitors for Inflammation
- (2009) Zhulun Wang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now